Hear directly from VCs and pharma BD leaders on what data packages, formats, and strategies attract investment:

• What pharma wants: therapeutic index, MoA clarity, and early efficacy signals
• Pre-IND vs. Phase I: where investors draw the line on risk
• Collaboration models and platform licensing strategies